Lathyrus sativus diamine oxidase reduces Clostridium difficile toxin A-induced toxicity in Caco-2 cells by rescuing RhoA-GTPase and inhibiting pp38-MAPK/NF-κB/HIF-1α activation.


Journal

Phytotherapy research : PTR
ISSN: 1099-1573
Titre abrégé: Phytother Res
Pays: England
ID NLM: 8904486

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 10 04 2020
revised: 16 06 2020
accepted: 01 07 2020
pubmed: 12 9 2020
medline: 24 2 2021
entrez: 11 9 2020
Statut: ppublish

Résumé

Clostridium difficile toxin A (TcdA) impairs the intestinal epithelial barrier, increasing the mucosa permeability and triggering a robust inflammatory response. Lathyrus sativus diamino oxidase (LSAO) is a nutraceutical compound successfully used in various gastrointestinal dysfunctions. Here, we evaluated the LSAO (0.004-0.4 μM) ability to counter TcdA-induced (30 ng/mL) toxicity and damage in Caco-2 cells, investigating its possible mechanism of action. LSAO has improved the transepithelial electrical resistance (TEER) score and increased cell viability in TcdA-treated cells, significantly rescuing the protein expression of Ras homolog family members, A-GTPase (RhoA-GTPase), occludin, and zonula occludens-1 (ZO-1). LSAO has also exhibited an anti-apoptotic effect by inhibiting the TcdA-induced expression of Bcl-2-associated X protein (Bax), p50 nuclear factor-kappa-B (p50), p65nuclear factor-kappa-B (p65), and hypoxia-inducible transcription factor-1 alpha (HIF-1α), and the release of tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and vascular endothelial growth factor (VEGF) in the cell milieu. Our data showed that LSAO exerts a protective effect on TcdA-induced toxicity in Caco-2 cells, placing itself as an interesting nutraceutical to supplement the current treatment of the Clostridium difficile infections.

Identifiants

pubmed: 32914548
doi: 10.1002/ptr.6814
doi:

Substances chimiques

Bacterial Toxins 0
Enterotoxins 0
IL6 protein, human 0
Interleukin-6 0
NF-kappa B 0
TJP1 protein, human 0
Tumor Necrosis Factor-alpha 0
VEGFA protein, human 0
Vascular Endothelial Growth Factor A 0
Zonula Occludens-1 Protein 0
tcdA protein, Clostridium difficile 0
RHOA protein, human 124671-05-2
Amine Oxidase (Copper-Containing) EC 1.4.3.21
GTP Phosphohydrolases EC 3.6.1.-
rhoA GTP-Binding Protein EC 3.6.5.2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

415-423

Subventions

Organisme : FINANZIAMENTO ANNUALE INDIVIDUALE DELLE ATTIVITA' BASE DI RICERCA, Prof. Giuseppe Esposito", LEGGE 11 DICEMBRE 2016 N.232
Organisme : Fondation Courtois (Québec, Canada)
Organisme : Joint Project Italia-Canada-Quebec (2017-2020)

Informations de copyright

© 2020 John Wiley & Sons, Ltd.

Références

Calinescu, C., Mondovi, B., Federico, R., Ispas-Szabo, P., & Mateescu, M. A. (2012). Carboxymethyl starch: Chitosan monolithic matrices containing diamine oxidase and catalase for intestinal delivery. International Journal of Pharmaceutics, 428(1-2), 48-56. https://doi.org/10.1016/j.ijpharm.2012.02.032
Castagliuolo, I., Kelly, C. P., Qiu, B. S., Nikulasson, S. T., LaMont, J. T., & Pothoulakis, C. (1997). IL-11 inhibits Clostridium difficile toxin a enterotoxicity in rat ileum. The American Journal of Physiology, 273(2 Pt 1), G333-G341. https://doi.org/10.1152/ajpgi.1997.273.2.G333
Chandrasekaran, R., & Lacy, D. B. (2017). The role of toxins in Clostridium difficile infection. FEMS Microbiology Reviews, 41(6), 723-750. https://doi.org/10.1093/femsre/fux048
Esposito, G., Nobile, N., Gigli, S., Seguella, L., Pesce, M., d'Alessandro, A., … Sarnelli, G. (2016). Rifaximin improves Clostridium difficile toxin A-induced toxicity in Caco-2 cells by the PXR-dependent TLR4/MyD88/NF-κB pathway. Frontiers in Pharmacology, 7(120), 1-8. https://doi.org/10.3389/fphar.2016.00120
Fanning, A. S., Jameson, B. J., Jesaitis, L. A., & Anderson, J. M. (1998). The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the Actin cytoskeleton. The Journal of Biological Chemistry, 273(45), 29745-29753. https://doi.org/10.1074/jbc.273.45.29745
Güvenilir, Y. A., & Deveci, N. (1996). The isolation and purification of diamine oxidase of pea seedlings and pig liver. Applied Biochemistry and Biotechnology, 56(3), 235-241. https://doi.org/10.1007/BF02786955
Han, M., Song, Y., & Zhang, X. (2016). Quercetin suppresses the migration and invasion in human colon cancer Caco-2 cells through regulating toll-like receptor 4/nuclear factor-kappa B pathway. Pharmacognosy Magazine, 12(Suppl 2), S237-244. https://doi.org/10.4103/0973-1296.182154
Hecht, G., Pothoulakis, C., LaMont, J. T., & Madara, J. L. (1988). Clostridium difficile toxin a perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers. The Journal of Clinical Investigation, 82(5), 1516-1524. https://doi.org/10.1172/jci113760
Huang, J., Kelly, C. P., Bakirtzi, K., Villafuerte Gálvez, J. A., Lyras, D., Mileto, S. J., … Chen, X. (2019). Clostridium difficile toxins induce VEGF-A and vascular permeability to promote disease pathogenesis. Nature Microbiology, 4(2), 269-279. https://doi.org/10.1038/s41564-018-0300-x
Huynh-Delerme, C., Huet, H., Noël, L., Frigieri, A., & Kolf-Clauw, M. (2005). Increased functional expression of P-glycoprotein in Caco-2 TC7 cells exposed long-term to cadmium. Toxicology In Vitro: An International Journal Published in Association with BIBRA, 19(4), 439-447. https://doi.org/10.1016/j.tiv.2004.08.003
Just, I., Wilm, M., Selzer, J., Rex, G., von Eichel-Streiber, C., Mann, M., & Aktories, K. (1995). The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the rho proteins. The Journal of Biological Chemistry, 270(23), 13932-13936. https://doi.org/10.1074/jbc.270.23.13932
Lessa, F. C., Winston, L. G., & McDonald, L. C. (2015). Burden of Clostridium difficile infection in the United States. The New England Journal of Medicine, 372(24), 2369-2370. https://doi.org/10.1056/NEJMc1505190
Madara, J. L. (1988). Tight junction dynamics: Is paracellular transport regulated? Cell, 53(4), 497-498. https://doi.org/10.1016/0092-8674(88)90562-4
McGrath, A. P., Hilmer, K. M., Collyer, C. A., Shepard, E. M., Elmore, B. O., Brown, D. E., … Guss, J. M. (2009). Structure and inhibition of human diamine oxidase. Biochemistry, 48(41), 9810-9822. https://doi.org/10.1021/bi9014192
McGuire, T., Dobesh, P., Klepser, D., Rupp, M., & Olsen, K. (2009). Clinically important interaction between statin drugs and Clostridium difficile toxin? Medical Hypotheses, 73(6), 1045-1047. https://doi.org/10.1016/j.mehy.2009.06.058
Mondovi, B., Fogel, W. A., Federico, R., Calinescu, C., Mateescu, M. A., Rosa, A. C., & Masini, E. (2013). Effects of amine oxidases in allergic and histamine-mediated conditions. Recent Patents on Inflammation & Allergy Drug Discovery, 7(1), 20-34.
Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65(1-2), 55-63. https://doi.org/10.1016/0022-1759(83)90303-4
Neree, A. T., Pietrangeli, P., Szabo, P. I., Mateescu, M. A., & Marcocci, L. (2018). Stability of vegetal Diamine oxidase in simulated intestinal media: Protective role of Cholic acids. Journal of Agricultural and Food Chemistry, 66(48), 12657-12665. https://doi.org/10.1021/acs.jafc.8b04005
Pawlowski, J., & Kraft, A. S. (2000). Bax-induced apoptotic cell death. Proceedings of the National Academy of Sciences of the United States of America, 97(2), 529-531. https://doi.org/10.1073/pnas.97.2.529
Pietrangeli, P., Capuozzo, E., Mateescu, M. A., & Marcocci, L. (2020). Copper-containing amine oxidase purified from Lathyrus sativus as a modulator of human neutrophil functions. International Journal of Molecular Medicine, 45, 1583-1590.
Pietrangeli, P., Federico, R., Mondovì, B., & Morpurgo, L. (2007). Substrate specificity of copper-containing plant amine oxidases. Journal of Inorganic Biochemistry, 101(7), 997-1004. https://doi.org/10.1016/j.jinorgbio.2007.03.014
Pietrangeli, P., Seguella, L., Annunziata, G., Casano, F., Capuano, R., Pesce, M., … Marcocci, L. (2019). Lathyrus sativus diamine oxidase counteracts histamine-induced cell proliferation, migration and pro-angiogenic mediators release in human colon adenocarcinoma cell line Caco-2. Phytotherapy Research: PTR, 33(7), 1878-1887. https://doi.org/10.1002/ptr.6378
Riegler, M., Sedivy, R., Pothoulakis, C., Hamilton, G., Zacherl, J., Bischof, G., … LaMont, J. T. (1995). Clostridium difficile toxin B is more potent than toxin a in damaging human colonic epithelium in vitro. The Journal of Clinical Investigation, 95(5), 2004-2011. https://doi.org/10.1172/JCI117885
Smits, W. K., Lyras, D., Lacy, D. B., Wilcox, M. H., & Kuijper, E. J. (2016). Clostridium difficile infection. Nature Reviews. Disease Primers, 2, 16020. https://doi.org/10.1038/nrdp.2016.20
Sun, X., Savidge, T., & Feng, H. (2010). The enterotoxicity of Clostridium difficile toxins. Toxins, 2(7), 1848-1880. https://doi.org/10.3390/toxins2071848
Voth, D. E., & Ballard, J. D. (2005). Clostridium difficile toxins: Mechanism of action and role in disease. Clinical Microbiology Reviews, 18(2), 247-263. https://doi.org/10.1128/CMR.18.2.247-263.2005
Wells, C. L., van de Westerlo, E. M., Jechorek, R. P., Haines, H. M., & Erlandsen, S. L. (1998). Cytochalasin-induced Actin disruption of polarized enterocytes can augment internalization of bacteria. Infection and Immunity, 66(6), 2410-2419.
Westphal, D., Dewson, G., Czabotar, P. E., & Kluck, R. M. (2011). Molecular biology of Bax and Bak activation and action. Biochimica et Biophysica Acta, 1813(4), 521-531. https://doi.org/10.1016/j.bbamcr.2010.12.019
Wu, X. X., Huang, X. L., Chen, R. R., Li, T., Ye, H. J., Xie, W., … Cao, G. Z. (2019). Paeoniflorin prevents intestinal barrier disruption and inhibits lipopolysaccharide (LPS)-induced inflammation in Caco-2 cell monolayers. Inflammation, 42(6), 2215-2225. https://doi.org/10.1007/s10753-019-01085-z
Yu, H., Chen, K., Sun, Y., Carter, M., Garey, K. W., Savidge, T. C., … Feng, H. (2017). Cytokines are markers of the Clostridium difficile-induced inflammatory response and predict disease severity. Clinical and Vaccine Immunology: CVI, 24(8), e00037-17. https://doi.org/10.1128/CVI.00037-17

Auteurs

Paola Pietrangeli (P)

Department of Biochemical Sciences "A. Rossi Fanelli", Faculty of Pharmacy and Medicine, Sapienza University of Rome, Rome, Italy.

Chiara Corpetti (C)

Department of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, Rome, Italy.

Luisa Seguella (L)

Department of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, Rome, Italy.

Alessandro Del Re (A)

Department of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, Rome, Italy.

Marcella Pesce (M)

Department of Clinical Medicine and Surgery, section of Gastroenterology, University Federico II, Naples, Italy.

Martina Vincenzi (M)

Department of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, Rome, Italy.

Chiara Lori (C)

Department of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, Rome, Italy.

Giuseppe Annunziata (G)

Department of Pharmacy, University Federico II, Naples, Italy.

Mircea A Mateescu (MA)

Department of Chemistry and Centre CERMO-FC, Université du Québec à Montreal, CP8888 Branch A, Montreal (Québec), Montreal, Québec, Canada.

Giovanni Sarnelli (G)

Department of Clinical Medicine and Surgery, section of Gastroenterology, University Federico II, Naples, Italy.

Giuseppe Esposito (G)

Department of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, Rome, Italy.

Lucia Marcocci (L)

Department of Biochemical Sciences "A. Rossi Fanelli", Faculty of Pharmacy and Medicine, Sapienza University of Rome, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH